View drug registration information details.


ItemsRegistration information
ID8
No8
Brand NameGLYCIKAM SR G2
IngredientsMETFORMIN HYDROCHLORIDE BP 500 MG, GLIMEPIRIDE BP 2 MG
Dosage FormPROLONGED RELEASE TABLET
Primary PackagingALU-ALU BLISTER
StorageSTORE BELOW 30 C
Shelf Life3 YEARS
Pack SizeBOX OF 3 X 10'S
Dispensing CategoryPRESCRIPTION
ATC Classification
Pharmaceutical ClassANTIDIABETE
IndicationsAS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETE WHO ARE ALREADY TREATED WITH COMBINATION OF GLIMEPIRID AND METFORMIN OR WHOSE DIABETES IS NOT ADEQUATELY CONTROLLED WITH METFORMIN ALONE.
ContraindicationsRENAL DISEASE AND RENAL DYSDUNCTION, HEPATIC IMPAIRMENT, HYPERSENSITIVITY
Side EffectsNAUSEA, DIARRHEA, CONSTIPATION, RASH, PRURITUS, HEADACHE, DIZZINESS, LEUKOPENIA
Unit Price
EDL No
DescriptionORANGE AND WHITE COLORED, CAPSULE SHAPED, BICONVEX UNCOATED BILAYERED TABLETS HAVING BREAKLINE ON ONE SIDE AND PLAIN ON THE OTHER
Note
License OwnerASA LAO SOLE COMPANY LIMITED
ManufacturerIMPULSE PHARMA PVT. LTD
CountryINDIA
Import Registration NoKD641 (FORM 25)
Import Registration Date2022-10-02
ActivityCERTIFICATE RELEASED
Applied Date2024-02-23
FDD Registration No09 I 5797/24
FDD Registration Date2024-09-25
Expiry Date2029-09-24

Back to drug list